Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.580
-0.140 (-3.76%)
At close: Jul 31, 2026, 4:00 PM EDT
3.590
+0.010 (0.28%)
After-hours: Jul 31, 2026, 7:59 PM EDT
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $273.14 million as of July 31, 2026. Its market cap has decreased by -26.82% in one year.
Market Cap
273.14M
Enterprise Value
-40.42M
1-Year Change
-26.82%
Ranking
Category
Stock Price
$3.58
ChartMarket Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $273.14M, a decrease of -9.45%. That is a compound annual growth rate of -1.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 273.14M | -63.39% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 250.21M |
| InflaRx | 246.72M |
| Turn Therapeutics | 245.75M |
| Orchestra BioMed Holdings | 243.03M |
| Surrozen | 241.61M |
| ProQR Therapeutics | 241.32M |
| Entrada Therapeutics | 239.98M |
| MacroGenics | 233.28M |